Copyright
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Jun 5, 2025; 16(2): 105375
Published online Jun 5, 2025. doi: 10.4292/wjgpt.v16.i2.105375
Published online Jun 5, 2025. doi: 10.4292/wjgpt.v16.i2.105375
Figure 2 Diagram illustrating microbiome-targeted interventions, including probiotics, prebiotics, dietary interventions, and fecal microbiota transplantation.
GOS: Galactooligosaccharide; FOS: Fructooligosaccharide; SCFA: Short-chain fatty acid.
- Citation: Bangolo A, Amoozgar B, Habibi M, Simms E, Nagesh VK, Wadhwani S, Wadhwani N, Auda A, Elias D, Mansour C, Abbott R, Jebara N, Zhang L, Gill S, Ahmed K, Ip A, Goy A, Cho C. Exploring the gut microbiome’s influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies. World J Gastrointest Pharmacol Ther 2025; 16(2): 105375
- URL: https://www.wjgnet.com/2150-5349/full/v16/i2/105375.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i2.105375